Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thiamine Supplementation to Reduce Brain Injury in Alcohol Use Disorder
NCT07844720Phase 2Not yet recruiting
- Sponsor
- Inserm
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of thiamine in alcohol use disorder (AUD), sponsored by Inserm. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
thiamine
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT07844720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07844720.